biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Blow hard

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Aug 21, 2023 1:46pm

70 Views

Post# 35598245

RE:Blow hard

Hey, fuzzy, I see the numbers. No thumbs, low read count.

Did it ever occur to you that I'm memorializing stuff, putting it on the public record?

Now, you're a smart guy, tell the forum what that means with respect to popularity contests, beauty pageants and thumbs shoved up.

You can do it. Think about it. Do I care what people think about the stuff I post?

Bioasis is a bad company with a great technology. It's no longer possible to satisfy anybody with any discussion about the company.

Do you and others not really get that?

You can do better.

jd

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for Nov. 14, 2024